Form 4 for STE Steris
Accepted 2023-10-04 00:00:00 ET · period of report 2023-10-02 · accession 0001209191-23-051986 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-10-04 | 2023-10-02 | STE | Xilas Andrew | SVP, GM, Dental | F - Tax | $215.50 | -85 | 5,809 | -1% | -$18.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2023-10-02 | F | D | 85 | $215.50 | 5,809 | D | — | — | (F1) 85 shares were withheld from the 289 restricted shares that vested on October 2, 2023. These 85 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 289 ordinary shares were awarded to Mr. Xilas on October 1, 2021. These vested shares were valued at the NYSE closing market price on October 2, 2023. (F2) As of October 2, 2023, 2,912 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 426 on May 31, 2024, 352 on June 3, 2024; 289 on October 1, 2024; 426 on June 2, 2025, 352 on June 2, 2025; 289 on October 1, 2025, 426 on June 1, 2026 and 352 on June 2, 2026. |